Global At-Home Testing Market Is Expected to Reach $45.58 Billion by 2031: Allied Market Research

Rise in awareness about the advantages offered by home-testing devices, rise in prevalence of chronic diseases, increase in the demand for HIV testing kits, diabetes kits, and various others, and the easy availability of self-testing kits at online stores and pharmacies without any prescription drive the growth of the global at-home testing market. By test type, the glucose test kits segment would maintain its leadership through 2031.

Portland, OR, Feb. 06, 2023 (GLOBE NEWSWIRE) — According to the report published by Allied Market Research, the global At-Home Testing Market generated $16.66 billion in 2021, and is estimated to reach $45.58 billion by 2031, witnessing a CAGR of 10.5% from 2022 to 2031. The report offers a detailed analysis of changing market trends, top segments, key investment pockets, value chains, regional landscape, and competitive scenario. The report is a helpful source of information for leading market players, new entrants, investors, and stakeholders in devising strategies for the future and taking steps to strengthen their position in the market.

Download Free Sample Report: https://www.alliedmarketresearch.com/request-sample/32316

Report coverage & details:

Report Coverage Details
   
Forecast Period 2022–2031
Base Year 2021
Market Size in 2021 $16.66 Billion
Market Size in 2031 $45.58 Billion
CAGR 10.5%
No. of Pages in Report 238
Segments Covered Test Type, Age Group, Distribution Channel, and Region
Drivers Increase in prevalence of chronic diseases
Rise in awareness about the advantages offered by home-testing devices
Increase in the demand for HIV testing kits, diabetes kits, and various others
The easy availability of self-testing kits at online stores and pharmacies without any prescription
Opportunities Surge in investments in R&D activities by pharmaceutical companies
Rise in technological advancements for the development of the latest at-home testing kits and devices
Restraints High risk of inaccurate results shown by at-home self-testing kits
Stringent government regulations for the release of testing kits

Covid-19 Scenario:

  • The outbreak of the COVID-19 pandemic impacted the at-home testing market positively, owing to the increased demand for self-testing kits.
  • The pandemic raised awareness among consumers regarding the use of self-testing kits, which is why, more people adopted self-help testing kits due to several restrictions in place.
  • The increased demand and production of at-home testing kits such as glucose monitoring devices, infectious diseases test kits, and other at-home testing kits increased the net revenue of firms working with the manufacturing and distribution of testing and diagnostic devices.

The report offers a detailed segmentation of the global at-home testing market based on test type, age group, distribution channel, and region. The report provides an analysis of each segment and sub-segment with the help of tables and figures. This analysis helps market players, investors, and new entrants in determining the sub-segments to be tapped on to achieve growth in the coming years.

Based on test type, the glucose test kits segment held the largest share of three-fifths of the global at-home testing market in 2021, and would maintain its leadership in terms of revenue through 2031. The same segment is estimated to witness the fastest CAGR of 11.0% during the forecast period. The report also analyzes the infectious diseases test kits, pregnancy test kits, cholesterol test strips, drugs of abuse test kits, coagulation monitoring tests, and others segments.

Purchase Inquiry: https://www.alliedmarketresearch.com/purchase-enquiry/32316

Based on age group, the adult segment was the largest in 2021, capturing nearly half of the global at-home testing market share, and would lead the trail through 2031. Moreover, the same segment is estimated to witness the fastest CAGR of 11.2% during the forecast period. The report also mentions the pediatric and geriatric segments.

Based on distribution channel, the retail pharmacies segment was the largest in 2021, grabbing more than two-fifths of the global at-home testing market share, and would maintain its dominance through 2031. The hospital pharmacies segment, on the other hand, is estimated to witness the fastest CAGR of 11.1% during the forecast period. The report also mentions the online pharmacies segment.

Based on region, the market in North America was the largest in 2021, accounting for two-fifths of the global at-home testing market share and is likely to maintain its leadership status during the forecast period. However, the market in Asia-Pacific is expected to manifest the highest CAGR of 11.6% from 2022 to 2031. The other regions analyzed in the study include Europe and LAMEA.

Leading players of the global at-home testing market analyzed in the research include ACON Laboratories, Inc., Quidel Corporation, Biomerieux SA, Everly Health, Inc., OraSure Technologies, Inc., PHC Holdings Corporation, B. Braun Melsungen AG, Cardinal Health Inc., Abbott Laboratories, and F. Hoffmann-La Roche Ltd.

The report analyzes these key players of the global at-home testing market. These players have adopted various strategies such as expansion, new product launches, partnerships, and others to increase their market penetration and strengthen their position in the industry. The report is helpful in determining the business performance, operating segments, product portfolio, and developments by every market player.

Trending Reports in Healthcare Industry (Book Now with 10% Discount):

Medical Tourism Market by Treatment Type (Dental Treatment, Cosmetic Treatment, Cardiovascular Treatment, Orthopedic Treatment, Neurological Treatment, Cancer Treatment, Fertility Treatment, and Others): Global Opportunity Analysis and Industry Forecast, 2019-2027

Gene Therapy Market by Vector Type (Viral Vector, Non Viral Vector), by Therapy (In Vivo Therapy, Ex Vivo Therapy), by Gene Type (Antigen, Cytokine, Tumor Suppressor, Suicide, Deficiency, Growth factors, Receptors, Others), by Application (Oncological Disorders, Rare Diseases, Neurological Disorders, Other Diseases): Global Opportunity Analysis and Industry Forecast, 2020-2030

U.S. Healthcare IT Market By Product Type (Healthcare Provider Solutions, Healthcare Payer Solutions, and HCIT Outsourcing Services) and End User (Healthcare Providers and Healthcare Payers) : Opportunity Analysis and Industry Forecast, 2021-2030

Opioids Market by Product Type (Methadone, Codeine, Fentanyl, Oxycodone, Morphine, Hydrocodone, Others), by Application (Pain Management, Cough Treatment, Diarrhea Treatment): Global Opportunity Analysis and Industry Forecast, 2020-2030

Fertility Services Market by Procedure (IVF with ICSI, IUI, IVF without ICSI, Surrogacy, and Others), Service (Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor, and Frozen Donor), and End User (Fertility Clinics, Hospitals, Surgical Centers, and Clinical Research Institutes): Global Opportunity Analysis and Industry Forecast, 2022–2031

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

CONTACT: David Correa 5933 NE Win Sivers Drive #205, Portland, OR 97220 United States USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022 UK: +44-845-528-1300 Hong Kong: +852-301-84916 India (Pune): +91-20-66346060 Fax: +1(855)550-5975 [email protected]

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. IndiaChron.com takes no editorial responsibility for the same.